HSIC
Henry Schein, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Buy
+22/100
Last price
84.84
▲ 0.61 (0.72%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
84.00
Prev close
84.23
Day high
86.40
Day low
84.31
Volume
1.42M
Market cap
$9.46B
P/E (TTM)
24.73
52W range
61.95 – 92.18
Day trading desk
Gap from prior close
-0.27%
Prior close 84.23
VWAP
84.93
-0.10% from price
Relative volume
1.90×
Unusually busy
Session range
7.58%
82.64 – 88.90
Position in range
35%
Mid range
ATR (14D)
1.93
2.28% of price
Prior day high
85.51
PDH
Prior day low
83.42
PDL
Bid / ask spread
—
Quote not published
Session volume
2.29M
Avg 1.20M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-0.15%
-2.1%
1M
-5.53%
-6.7%
3M
+1.95%
-2.6%
6M
+14.88%
-3.3%
YTD
+12.25%
-2.0%
1Y
+26.57%
+10.2%
3Y
+14.26%
-68.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on HSIC open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
928.35K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 12, 26 | DANIEL WILLIAM K Director |
STOCK | 2.21K | $0 | Direct |
| May 26, 26 | BERGMAN STANLEY M Director |
STOCK | 50 | $0 | Direct |
| May 21, 26 | BERGMAN STANLEY M Director |
STOCK | 50 | $0 | Direct |
| May 19, 26 | BERGMAN STANLEY M Director |
STOCK | 1.04K | $0 | Direct |
| May 11, 26 | DANIEL WILLIAM K Director |
BUY | 10.00K | $691.90K | Indirect |
| Mar 19, 26 | POPECK THOMAS C Officer |
SELL | 1.35K | $98.63K | Direct |
| Mar 17, 26 | ETTINGER MICHAEL S. Chief Operating Officer |
STOCK | 2.30K | $0 | Direct |
| Mar 16, 26 | BERGMAN STANLEY M Director |
STOCK | 400 | $0 | Direct |
| Mar 12, 26 | BERGMAN STANLEY M Director |
STOCK | 970 | $0 | Direct |
| Mar 10, 26 | KUEHN KURT P Director |
SELL | 2.84K | $224.56K | Direct |
| Mar 6, 26 | KUEHN KURT P Director |
STOCK | 2.58K | $0 | Direct |
| Mar 6, 26 | HOMBACH ROBERT J. CPA Director |
STOCK | 2.58K | $0 | Direct |
| Mar 6, 26 | ALI MOHAMAD S Director |
STOCK | 2.58K | $0 | Direct |
| Mar 6, 26 | MARGULIES ANNE H Director |
STOCK | 2.58K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ALBERTINI ANDREA |
Officer | 122.09K | Stock Award(Grant) |
BERGMAN STANLEY M |
Director | 643.12K | Stock Gift |
BRESLAWSKI JAMES P |
President | 206.54K | Stock Award(Grant) |
CONNETT BRADFORD C |
Officer | 62.69K | Sale |
ETTINGER MICHAEL S. |
Chief Operating Officer | 112.42K | Stock Gift |
LOWERY FREDERICK M. |
Chief Executive Officer | 95.16K | Stock Award(Grant) |
MLOTEK MARK E |
Officer | 89.04K | Stock Gift |
POPECK THOMAS C |
Officer | 86.18K | Sale |
SHEARES BRADLEY T |
Director | 47.62K | Stock Award(Grant) |
SOUTH RONALD N. CPA |
Chief Financial Officer | 94.15K | Stock Award(Grant) |
Fundamentals
Market cap$9.46B
Enterprise value$14.68B
Revenue (TTM)$13.60B
Gross profit$4.26B
EBITDA$1.08B
Net income$403.00M
EPS (TTM)$3.43
Free cash flow$446.00M
Total cash$157.00M
Total debt$3.81B
Book value / share$28.21
Shares outstanding111.45M
Float91.71M
Short % of float8.23%
Dividend yield0.00%
Beta (5Y)0.84
Valuation & profitability ratios
Trailing P/E24.73
Forward P/E14.17
PEG ratio1.68
Price / sales—
Price / book3.01
EV / revenue1.08
EV / EBITDA13.59
Gross margin31.32%
Operating margin5.76%
Profit margin2.96%
Return on equity8.85%
Return on assets4.39%
Debt / equity80.73
Current ratio1.32
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $13.18B | $12.67B | $12.34B | $12.65B | +4.0% |
| Operating revenue | $13.18B | $12.67B | $12.34B | $12.65B | +4.0% |
| Cost of revenue | $9.08B | $8.66B | $8.48B | $8.82B | +4.9% |
| Gross profit | $4.11B | $4.02B | $3.86B | $3.83B | +2.2% |
| Selling, general & admin | $3.08B | $3.03B | $2.96B | $2.77B | +1.6% |
| Total operating expense | $3.35B | $3.29B | $3.17B | $2.95B | +1.9% |
| Operating income | $758.00M | $731.00M | $695.00M | $878.00M | +3.7% |
| Net interest income | -$117.00M | -$107.00M | -$70.00M | -$27.00M | -9.3% |
| Pre-tax income | $533.00M | $513.00M | $542.00M | $721.00M | +3.9% |
| Tax provision | $126.00M | $128.00M | $120.00M | $170.00M | -1.6% |
| Net income | $398.00M | $390.00M | $416.00M | $538.00M | +2.1% |
| Net income to common | $398.00M | $390.00M | $416.00M | $538.00M | +2.1% |
| Basic EPS | 3.29 | 3.07 | 3.18 | 3.95 | +7.2% |
| Diluted EPS | 3.27 | 3.05 | 3.16 | 3.91 | +7.2% |
| EBIT | $683.00M | $644.00M | $629.00M | $756.00M | +6.1% |
| EBITDA | $964.00M | $912.00M | $851.00M | $950.00M | +5.7% |
| Basic shares | 120.81M | 126.79M | 130.62M | 136.06M | -4.7% |
| Diluted shares | 121.72M | 127.78M | 131.75M | 137.76M | -4.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $156.00M | $122.00M | $171.00M | $117.00M | +27.9% |
| Cash & short-term investments | $156.00M | $122.00M | $171.00M | $117.00M | +27.9% |
| Accounts receivable | $1.65B | $1.48B | $1.86B | $1.44B | +11.4% |
| Inventory | $2.00B | $1.81B | $1.81B | $1.96B | +10.6% |
| Total current assets | $4.46B | $3.98B | $4.49B | $3.99B | +12.1% |
| Property, plant & equipment | $922.00M | $824.00M | $823.00M | $667.00M | +11.9% |
| Goodwill & intangibles | $5.23B | $4.91B | $4.79B | $3.48B | +6.5% |
| Total assets | $11.21B | $10.22B | $10.57B | $8.61B | +9.8% |
| Total current liabilities | $3.23B | $2.80B | $2.68B | $2.22B | +15.2% |
| Current debt | $797.00M | $706.00M | $414.00M | $109.00M | +12.9% |
| Long-term debt | $2.31B | $1.83B | $1.94B | $1.04B | +26.2% |
| Total debt | $3.44B | $2.87B | $2.74B | $1.50B | +19.7% |
| Total liabilities | $6.42B | $5.38B | $5.42B | $3.94B | +19.3% |
| Retained earnings | $3.29B | $3.77B | $3.86B | $3.68B | -12.7% |
| Shareholder equity | $3.25B | $3.39B | $3.65B | $3.45B | -4.4% |
| Working capital | $1.24B | $1.18B | $1.80B | $1.76B | +4.7% |
| Net tangible assets | -$1.99B | -$1.52B | -$1.14B | -$34.00M | -30.9% |
| Shares issued | 115.77M | 124.16M | 129.25M | 131.79M | -6.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $419.00M | $398.00M | $436.00M | $566.00M | +5.3% |
| Depreciation & amortisation | $281.00M | $268.00M | $222.00M | $194.00M | +4.9% |
| Stock-based compensation | $39.00M | $39.00M | $39.00M | $54.00M | 0.0% |
| Change in working capital | -$48.00M | $140.00M | -$290.00M | -$281.00M | -134.3% |
| Operating cash flow | $712.00M | $848.00M | $500.00M | $602.00M | -16.0% |
| Capital expenditure | -$191.00M | -$187.00M | -$187.00M | -$128.00M | -2.1% |
| Investing cash flow | -$400.00M | -$430.00M | -$1.14B | -$276.00M | +7.0% |
| Share buybacks | -$850.00M | -$385.00M | -$250.00M | -$485.00M | -120.8% |
| Financing cash flow | -$188.00M | -$510.00M | $701.00M | -$315.00M | +63.1% |
| Free cash flow | $521.00M | $661.00M | $313.00M | $474.00M | -21.2% |
| End cash position | $156.00M | $122.00M | $171.00M | $117.00M | +27.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $3.46B | $3.37B | $3.44B | $3.34B | $3.24B | +2.7% |
| Operating revenue | $3.46B | $3.37B | $3.44B | $3.34B | $3.24B | +2.7% |
| Cost of revenue | $2.36B | $2.30B | $2.37B | $2.31B | $2.22B | +2.6% |
| Gross profit | $1.10B | $1.07B | $1.06B | $1.03B | $1.02B | +2.9% |
| Selling, general & admin | $831.00M | $809.00M | $808.00M | $760.00M | $778.00M | +2.7% |
| Total operating expense | $901.00M | $876.00M | $877.00M | $828.00M | $842.00M | +2.9% |
| Operating income | $200.00M | $194.00M | $186.00M | $198.00M | $174.00M | +3.1% |
| Net interest income | -$35.00M | -$32.00M | -$30.00M | -$29.00M | -$29.00M | -9.4% |
| Pre-tax income | $137.00M | $150.00M | $133.00M | $134.00M | $121.00M | -8.7% |
| Tax provision | $34.00M | $38.00M | $32.00M | $28.00M | $31.00M | -10.5% |
| Net income | $94.00M | $107.00M | $101.00M | $101.00M | $86.00M | -12.1% |
| Net income to common | $94.00M | $107.00M | $101.00M | $101.00M | $86.00M | -12.1% |
| Basic EPS | 0.83 | 0.93 | 0.86 | 0.84 | 0.71 | -10.8% |
| Diluted EPS | 0.82 | 0.92 | 0.85 | 0.84 | 0.70 | -10.9% |
| EBIT | $180.00M | $189.00M | $172.00M | $172.00M | $159.00M | -4.8% |
| EBITDA | $264.00M | $270.00M | $241.00M | $252.00M | $235.00M | -2.2% |
| Basic shares | 113.45M | 114.94M | 117.36M | 120.20M | 121.93M | -1.3% |
| Diluted shares | 114.39M | 116.06M | 118.34M | 121.04M | 122.64M | -1.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $157.00M | $138.00M | $156.00M | $136.00M | $145.00M | +13.8% |
| Cash & short-term investments | $157.00M | $138.00M | $156.00M | $136.00M | $145.00M | +13.8% |
| Accounts receivable | $1.76B | $1.72B | $1.65B | $1.74B | $1.65B | +2.6% |
| Inventory | $2.06B | $2.01B | $2.00B | $1.91B | $1.91B | +2.2% |
| Total current assets | $4.60B | $4.50B | $4.46B | $4.39B | $4.24B | +2.3% |
| Property, plant & equipment | $940.00M | $930.00M | $922.00M | $911.00M | $887.00M | +1.1% |
| Goodwill & intangibles | $5.24B | $5.29B | $5.23B | $5.19B | $5.13B | -1.0% |
| Total assets | $11.38B | $11.30B | $11.21B | $11.10B | $10.91B | +0.7% |
| Total current liabilities | $3.49B | $3.30B | $3.23B | $3.15B | $3.01B | +5.8% |
| Current debt | $1.16B | $1.08B | $797.00M | $943.00M | $928.00M | +7.5% |
| Long-term debt | $2.30B | $2.33B | $2.31B | $2.15B | $2.09B | -1.2% |
| Total debt | $3.81B | $3.75B | $3.44B | $3.44B | $3.36B | +1.7% |
| Total liabilities | $6.66B | $6.48B | $6.42B | $6.20B | $6.01B | +2.7% |
| Retained earnings | $3.20B | $3.29B | $3.29B | $3.38B | $3.48B | -2.6% |
| Shareholder equity | $3.16B | $3.27B | $3.25B | $3.36B | $3.44B | -3.3% |
| Working capital | $1.11B | $1.20B | $1.24B | $1.25B | $1.24B | -7.3% |
| Net tangible assets | -$2.08B | -$2.02B | -$1.99B | -$1.83B | -$1.68B | -2.7% |
| Shares issued | 111.92M | 114.42M | 115.77M | 118.57M | 121.90M | -2.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $102.00M | $112.00M | $103.00M | $109.00M | $94.00M | -8.9% |
| Depreciation & amortisation | $84.00M | $81.00M | $52.00M | $80.00M | $76.00M | +3.7% |
| Stock-based compensation | $13.00M | $3.00M | $10.00M | $13.00M | $11.00M | +333.3% |
| Change in working capital | $44.00M | -$278.00M | $173.00M | -$35.00M | -$61.00M | +115.8% |
| Operating cash flow | $242.00M | -$97.00M | $381.00M | $174.00M | $120.00M | +349.5% |
| Capital expenditure | -$46.00M | -$39.00M | -$57.00M | -$45.00M | -$46.00M | -17.9% |
| Investing cash flow | -$65.00M | -$63.00M | -$147.00M | -$56.00M | -$98.00M | -3.2% |
| Share buybacks | -$200.00M | -$125.00M | -$200.00M | -$203.00M | -$286.00M | -60.0% |
| Financing cash flow | -$168.00M | $120.00M | -$206.00M | -$127.00M | $56.00M | -240.0% |
| Free cash flow | $196.00M | -$136.00M | $324.00M | $129.00M | $74.00M | +244.1% |
| End cash position | $157.00M | $138.00M | $156.00M | $136.00M | $145.00M | +13.8% |
Options analytics
Put / call volume
0.41
Call-heavy session
Put / call open interest
33.00
Positioning, not flow
Max pain
70.00
-17.5% from spot
ATM implied vol
0.4%
Nearest strike to spot
Skew (10% OTM)
+86.4%
Puts bid over calls
Call volume
29
Contracts, this expiry
Put volume
12
Contracts, this expiry
Heaviest call OI
65.00
1 contracts
Heaviest put OI
60.00
41 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 1.24 | 1.27 | +2.5% |
| Mar 2026 | 1.22 | 1.32 | +8.4% |
| Dec 2025 | 1.29 | 1.34 | +3.5% |
| Sep 2025 | 1.28 | 1.38 | +7.9% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 1.36 | 16 | $3.48B | +4.1% |
| Next quarter | 1.45 | 16 | $3.57B | +3.8% |
| Current year | 5.39 | 16 | $13.86B | +5.1% |
| Next year | 5.99 | 16 | $14.42B | +4.1% |
Analyst targets & ownership
Mean target$97.27
High target$110.00
Low target$64.00
Implied upside14.65%
Analyst count15
ConsensusBUY
Strong buy / Buy4 / 4
Hold7
Sell / Strong sell1 / 0
Held by insiders0.83%
Held by institutions112.27%
Institutions holding785
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
85.08
-0.28% from price
SMA 20
86.01
-1.36% from price
SMA 50
87.69
-3.25% from price
SMA 100
84.23
+0.73% from price
SMA 200
80.34
+5.60% from price
EMA 12
85.32
-0.56% from price
EMA 26
86.26
-1.64% from price
EMA 50
86.31
-1.70% from price
RSI (14)
43.3
Neutral
MACD (12,26,9)
-0.94
Hist -0.13
ATR (14)
1.93
2.28% of price
Realised vol 30D
18.7%
Annualised
Bollinger upper
88.87
20, 2σ
Bollinger lower
83.15
20, 2σ
50 / 200 cross
Golden
87.69 vs 80.34
Trend bias
Above 200
+5.60%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.50
Less volatile than market
Correlation to SPY
0.26
Largely independent
Realised vol 30D
18.7%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-17.2%
Peak to trough
Max drawdown 5Y
-32.7%
Peak to trough
ATR 14
1.93
2.28% of price
Beta (reported)
0.84
5Y monthly, from filing
Short interest
Shares short
7.57M
Prior 6.91M
Change vs prior
+9.5%
Shorts adding
% of float
8.23%
Normal
% of shares out
6.79%
Against total outstanding
Days to cover
8.3
Crowded exit
Float
91.71M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 19, 26 | BTIG | MAINTAINED | Buy | Buy |
| Aug 6, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Aug 5, 26 | UBS | MAINTAINED | Neutral | Neutral |
| Aug 5, 26 | Citigroup | MAINTAINED | Buy | Buy |
| Aug 5, 26 | BTIG | MAINTAINED | Buy | Buy |
| Jul 29, 26 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Jul 28, 26 | UBS | MAINTAINED | Neutral | Neutral |
| Jul 9, 26 | BMO Capital | INITIATED | — | Market Perform |
| Jun 11, 26 | BTIG | UPGRADE | Neutral | Buy |
| May 6, 26 | UBS | MAINTAINED | Neutral | Neutral |
| May 6, 26 | Mizuho | MAINTAINED | Neutral | Neutral |
| Apr 24, 26 | Morgan Stanley | MAINTAINED | Underweight | Underweight |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split1275:1000
Split dateFeb 8, 2019
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-22
Corporate Changes & Voting Matters
8-K · 2026-08-04
Corporate Changes & Voting Matters
8-K · 2026-07-30
Annual report of employee stock purchase
11-K · 2026-06-18
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-29
Corporate Changes & Voting Matters
8-K · 2026-05-22
Proxy Statements
DEFA14A · 2026-05-12
Periodic Financial Reports
10-Q · 2026-05-05
Headlines
HSIC or MMSI: Which Is the Better Value Stock Right Now?
Zacks · 15h ago
Should Value Investors Buy Henry Schein (HSIC) Stock?
Zacks · 17h ago
Dental Implants and Prosthetics Market Forecasts Growth from $12.79B (2026) to $17.67B by 2031, Profiling Institut Straumann, Envista, Dentsply Sirona & Henry Schein
GlobeNewswire · 6d ago
Henry Schein Cares Marks 25 Years of Helping Health Happen®
Business Wire · 7d ago
Henry Schein (HSIC): Buy, Sell, or Hold Post Q2 Earnings?
StockStory · 8d ago
Henry Schein (HSIC) Extends Credit Facility, Is The Stock Still Undervalued?
Simply Wall St. · 10d ago
Henry Schein (HSIC) Stock Looks Below Fair Value Even After A 31% Gain
Simply Wall St. · 11d ago
3 Cash-Producing Stocks That Concern Us
StockStory · 12d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.